Tumour markers, enzymes and hormonal markers
Schwartz, M.K.
Clinics in Gastroenterology 5(3): 653-663
1976
ISSN/ISBN: 0300-5089 PMID: 1022378 Document Number: 105186
Document emailed within 1 workday
Related Documents
Avall Lundqvist, E.; Nordström, L.; Sjövall, K.; Eneroth, P. 1989: Evaluation of seven different tumour markers for the establishment of tumour marker panels in gynecologic malignancies European Journal of Gynaecological Oncology 10(6): 395-405Tonkin, K.S.; Rustin, G.J.; Wignall, B.; Paradinas, F.; Bennett, M. 1989: Successful treatment of patients in whom germ cell tumour masses enlarged on chemotherapy while their serum tumour markers decreased European Journal of Cancer and Clinical Oncology 25(12): 1739-1743
Torre, G.C.; Lucchese, V.; Rembado, R.; Barbetti, V. 1996: Tumour markers: from laboratory to clinical use Anticancer Research 16(4b): 2215-2219
Lai, L.C.; Cheong, S.K.; Goh, K.L.; Leong, C.F.; Loh, C.S.; Lopez, J.B.; Nawawi, H.; Sivanesaratnam, V.; Subramaniam, R. 2003: Clinical usefulness of tumour markers Malaysian Journal of Pathology 25(2): 83-105
Aw, S.E.; Sundram, F.X. 1990: Tumour markers--a diagnostic and therapeutic perspective Annals of the Academy of Medicine Singapore 19(2): 244-250
Ioachin, E. 2005: Immunohistochemical tumour markers in endometrial carcinoma European Journal of Gynaecological Oncology 26(4): 363-371
Hodgkiss, R.J. 1998: Use of 2-nitroimidazoles as bioreductive markers for tumour hypoxia Anti-Cancer Drug Design 13(6): 687-702
Gargano, G.; Correale, M.; Abbate, I.; Falco, G.; De Frenza, N.; Lorusso, V.; De Lena, M.; De Leonardis, A. 1990: The role of tumour markers in ovarian cancer Clinical and Experimental Obstetrics and Gynecology 17(1): 23-29
Sparholt, M.H.; Høgdall, E.; Høgdall, C.K. 2009: Tumour markers in epithelial ovarian cancer Ugeskrift for Laeger 171(48): 3505-3509
Higgins, C. 1996: Use of tumour markers in cancer diagnosis and treatment Nursing Times 92(16): 36-37
Eskelinen, M.; Kataja, V.; Hämäläinen, E.; Kosma, V.M.; Penttilä, I.; Alhava, E. 1997: Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer Anticancer Research 17(2b): 1231-1234
Kardamakis, D. 1996: Tumour serum markers: clinical and economical aspects Anticancer Research 16(4b): 2285-2288
Fossa, S.D.; Paus, E. 1985: Pre-, per- and post-chemotherapy tumour markers in very advanced testicular cancer Progress in Clinical and Biological Research 203: 121
Langmann, G.; Kleinert, R.; Wirnsberger, G.H.; Faulborn, J.; Faschinger, C. 1993: Proliferation markers, enzyme markers and oncogene expression profile of intraocular melanoma Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 90(5): 528-532
Khalifa, A.; Mady, E.A.; Abadeer, N.; Kamal, A. 1999: Differential tumor markers and hepatitis markers profile in liver tumors Anticancer Research 19(4a): 2495-2500
Muramatsu, T. 1988: Function of carbohydrate chains serving as tumor-markers and differentiation markers Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 79: 27-36
Kanoh, Y. 2011: Biochemical markers and physiological tests of atherosclerosis--changes and usefulness of markers in anti-atherosclerotic therapy Rinsho Byori. Japanese Journal of Clinical Pathology 59(1): 80-88
Nano, M.; Ricci, E.; Pecchio, F.; Rapellino, M.; Giaccone, M.; Molaschi, M. 1988: Relations between markers and immunological status in surgical patients. Tumor markers and immunity in surgery Minerva Medica 79(11): 943-946
Zola, H. 1992: Phenotypic markers for functional lymphocyte populations: a critical appraisal of current usage as disease markers and future prospects Disease Markers 10(2): 53-66
Hergesell, O.; Andrassy, K.; Nawroth, P. 1996: Elevated levels of markers of endothelial cell damage and markers of activated coagulation in patients with systemic necrotizing vasculitis Thrombosis and Haemostasis 75(6): 892-898